3D spheroids derived from single cells for discovering stochastic patterns behind metastasis
3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.
Projectdetails
Introduction
Metastasis remains accountable for 9 out of 10 fatalities within cancer disease. However, the mechanisms governing the onset of metastasis are far from being fully understood. Notably, metastases are predominantly clonal and arise from a single cell.
Project Overview
3DSecret will investigate metastasis from a radically new perspective, with the overarching goal of unravelling stochastic patterns at the single-cell level with predictive and prognostic capacity.
Importance of the Study
Critically, defining the hallmarks of metastasis from holistic studies of single circulating tumour cells (CTCs), thus dissecting tumour heterogeneity, has the power to revolutionise cancer treatment and diagnosis. This will pave the way for game-changing discoveries in what is one of the holy grails of modern clinical science.
Methodology
To achieve our goal, 3DSecret will use a set of key enabling technologies including:
- Microfluidics
- Nanosensors
- Genomics
- Artificial intelligence (AI)
Microfluidics will drive the isolation of single CTCs from whole blood samples of 60+ metastatic breast cancer patients. These will be grown on-chip to form 3D spheroids, thus allowing comprehensive genomic and transcriptomic studies of single-cell origin while bypassing the errors typically introduced by single-cell genome amplification.
Data Integration
The genomic and transcriptomic data will be combined with:
- Clinical information
- Single-cell growth profiles
- Dynamic metabolomic analyses obtained by the use of nanosensors and SERS
This integration aims to develop a multimodal AI analytical tool capable of identifying unknown patterns driving metastasis.
Risk and Reward
The bold assumption that there could be stochastic patterns driving metastasis, cancer evolution, and malignancy makes the approach of 3DSecret exceptionally high-risk, high-gain.
Conclusion
We are confident that such a breakthrough would lead to a major paradigm shift with significant implications in biology, physics, disruptive technologies such as AI, and critically, in the medical arena and patient care.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.591.050 |
Totale projectbegroting | € 2.591.050 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2026 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORYpenvoerder
- UNIVERSIDAD DE VIGO
- FONDAZIONE BRUNO KESSLER
- CCAB - CENTRO CLINICO ACADEMICO - BRAGA ASSOCIACAO
- FUNDACION TECNALIA RESEARCH & INNOVATION
- SPHERE FLUIDICS LIMITED
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Proteomic Analysis of Cell communication in TumorsThis project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells. | ERC COG | € 2.000.000 | 2022 | Details |
Clone-based full-length RNA-seq for early diagnosis of cancerDeveloping a novel 3D clone-based RNA-seq technology to enhance detection of rare mutations and splicing in cancer cells for improved early diagnosis and personalized treatment strategies. | ERC POC | € 150.000 | 2022 | Details |
Integrative profiling and engineering of clonal cancer cell behaviours: from the tissue level down to the molecular scaleSpaceClones aims to elucidate clonal interactions in tumors using advanced imaging and engineering techniques to enhance cancer therapy effectiveness and predict clinical outcomes. | ERC STG | € 2.499.999 | 2024 | Details |
Deciphering Cancer Heterogeneity and Drug resistance using Single-Clone Genomic and Epigenomic LandscapesThis project aims to develop innovative single-cell technologies to analyze tumor subclones, enhancing understanding of drug resistance and identifying new therapeutic targets in brain cancers. | ERC COG | € 2.000.000 | 2023 | Details |
Proteomic Analysis of Cell communication in Tumors
This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.
Clone-based full-length RNA-seq for early diagnosis of cancer
Developing a novel 3D clone-based RNA-seq technology to enhance detection of rare mutations and splicing in cancer cells for improved early diagnosis and personalized treatment strategies.
Integrative profiling and engineering of clonal cancer cell behaviours: from the tissue level down to the molecular scale
SpaceClones aims to elucidate clonal interactions in tumors using advanced imaging and engineering techniques to enhance cancer therapy effectiveness and predict clinical outcomes.
Deciphering Cancer Heterogeneity and Drug resistance using Single-Clone Genomic and Epigenomic Landscapes
This project aims to develop innovative single-cell technologies to analyze tumor subclones, enhancing understanding of drug resistance and identifying new therapeutic targets in brain cancers.